U.S. Department of Health and Human Services
Beena Akolkar
 

 Contact Info

 
Tel: 240-593-1733
Email: akolkarb@mail.nih.gov
 

 Select Experience

 
  • Assistant ProfessorMedicine and Pathology, NYU School of Medicine, Division of Molecular Medicine, Department of Medicine, North Shore University Hospital1996-2000
  • InstructorCell Biology, NYU School of Medicine, Division of Molecular Medicine, Department of Medicine, North Shore University1995-1996
  • InstructorDepartment of Medicine, Cornell University Medical College, North Shore University Hospital1992-1995
  • Research AssociateDepartment of Medicine, Cornell University Medical College, North Shore University Hospital1989-1992
  • Research AssociateDepartment of Microbiology and Biotechnology Centre, University of Baroda, Baroda, India1987-1989

Beena Akolkar, Ph.D.

Program Director, Division of Diabetes, Endocrinology, and Metabolic Diseases

Current Responsibilities & Activities

I am the program director for the Immunopathogenesis and genetics of Diabetes. My portfolio includes basic and clinical research on the genetics, immunopathogenesis, prevention, and treatment of type 1 diabetes (T1D) and genetics and genomics of type 2 diabetes (T2D).

I am the project scientist for the Environmental Determinants of Diabetes in the Young (TEDDY) study, an international consortium established with the goal of developing and carrying out studies to identify environmental triggers of T1D, such as infectious agents, dietary factors, and/or psychosocial factors, in genetically susceptible individuals.

I am the project scientist for the Accelerating Medicines Partnership in Type 2 Diabetes (AMP-T2D-GENES).

I also serve as a project officer for the NIDDK Central Repositories.  My responsibilities also include coordinating research activities on autoimmunity and transplant across the Division and T1D across the NIH.

​Research Programs

Clinical Research in Type 1 Diabetes
This program supports clinical research that addresses the determinants, etiology, progression, prevention, and treatment of type 1 diabetes in children and adults

Diabetes Genetics and Genomics
This program advances research to identify the genetic mechanisms underlying type 1 and type 2 diabetes—and how genetic and epigenetic variation influences the metabolism of therapeutics—with an aim towards developing better treatments

Diabetes: Treatment, Prevention, and Complications
This program supports both basic and clinical studies aimed at addressing the prevention, treatment, and pathophysiology of type 1 and type 2 diabetes

Current Committee Memberships

  • Type 1 Diabetes Working GroupChair
  • Clinical Sciences Working GroupMember
  • Human Microbiome Project GroupRepresentative
  • Translation Working GroupMember
  • NIDDK Clinical Sciences Working GroupMember
  • Genomics Working GroupMember
  • TrialNet, Ancillary, Laboratory, and Mechanistic CommitteesRepresentative
  • Immune Tolerance Network Steering and Executive CommitteeMember
  • Autoimmunity Centers of Excellence Steering CommitteeRepresentative
  • CSGADP Steering CommitteeMember
  • Autoimmunity/Transplant Working GroupChair
  • TRIGR Steering CommitteeMember